Arcutis Presents New Phase 2 Results in Infants with Atopic Dermatitis in Late-Breaking Session Today at the 2026 American Academy of Dermatology Annual Meeting

Go back to Arcutis Presents New Phase 2 Results in Infants with Atopic Dermatitis in Late-Breaking Session Today at the 2026 American Academy of Dermatology Annual Meeting
(NASDAQ: ARQT) Delayed: 26.60 -0.06 (0.23%)
Previous Close $26.66    52 Week High
Open $26.56    52 Week Low
Day High $27.17    P/E N/A 
Day Low $26.42    EPS
Volume 429,277       

(NASDAQ: ARQT) Delayed: 26.60 -0.06 (0.23%)
Previous Close $26.66    52 Week High
Open $26.56    52 Week Low
Day High $27.17    P/E N/A 
Day Low $26.42    EPS
Volume 429,277